Clinical trial
PROTECT-TIMI 30 Trial
NCT00250471 · Millennium Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT00250471 |
|---|---|
| Title | PROTECT-TIMI 30 Trial |
| Official title | A Randomized Trial to Evaluate the Relative Protection Against Post-PCI Microvascular Dysfunction and Post-PCI Ischemia Among Anti-Platelet and Anti-Thrombotic Agents |
| Lead sponsor | Millennium Pharmaceuticals, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Unstable Angina |
| Intervention type | Procedure |
| Interventions | Percutaneous Coronary Intervention (PCI) |
| Enrollment | 900 |
| Start date | May 1, 2003 |
| Completion | Sep 1, 2004 |
| First posted | Nov 8, 2005 |
| Last update posted | Nov 8, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: